New Product Development
The global oligonucleotide API market is poised for significant growth, with demand projected to rise at a robust compound annual growth rate (CAGR) of 5.6% from 2024 to 2034. The market, valued at USD 2.81 billion in 2024, is anticipated to reach USD 4.84 billion by the end of 2034, driven by the growing need …
Continue reading “Oligonucleotide API Industry to Reach USD 4.84 Billion by 2034 at 5.60% CAGR”
The global vaginitis treatment drug market is projected to grow steadily, expanding from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, at a compound annual growth rate (CAGR) of 4.8%. This growth is driven by increasing awareness of women’s health, rising prevalence of vaginitis, and heightened demand for effective treatments for bacterial …
The global injectable benzodiazepines market is anticipated to grow steadily, with a projected growth rate exceeding 2.7% in 2020. Key drivers of this growth include increasing adoption of generic injectable benzodiazepines, rising prevalence of mental disorders, and short-term demand spikes caused by the COVID-19 pandemic, which has elevated anxiety levels globally. Short-acting injectable benzodiazepines are …
The global home healthcare market is projected to grow steadily from a valuation of USD 3.2 billion in 2023 to USD 4.4 billion by 2033, registering a compound annual growth rate (CAGR) of 3.1% during the forecast period. The market’s growth is fueled by rising demand for accessible and cost-effective healthcare solutions, particularly among aging …
Continue reading “Home Healthcare Industry to Reach USD 4.4 Billion by 2033, Growing at 3.1% CAGR”
The global market for eye infections treatment is forecasted to grow steadily, with sales expected to rise from USD 8,125.2 million in 2025 to USD 11,890.2 million by 2035. This reflects a compound annual growth rate (CAGR) of 3.9% over the forecast period. In 2024, the market generated revenue of USD 7,860.1 million, highlighting a …
The global Dual and Multi-energy Computed Tomography (CT) market is set to experience robust growth, expanding at a compound annual growth rate (CAGR) of 8.2% from 2022 to 2029. The market, valued at USD 1.5 billion in 2022, is projected to reach USD 2.6 billion by the end of 2029. This significant expansion is attributed …
The global medical protective equipment market is poised to grow significantly, with its value projected to reach USD 52.8 billion by 2033, advancing at a compound annual growth rate (CAGR) of 9.5% from current levels. Key factors driving this growth include the rising prevalence of workplace injuries, increasing adoption in healthcare settings, and heightened consumer …
The global medical mask market is projected to grow significantly, with its value rising from USD 6,017.30 million in 2024 to an impressive USD 16,780.20 million by 2034, reflecting a robust CAGR of 10.8% during the forecast period. The rising adoption of medical masks is attributed to their effectiveness in mitigating disease severity and protecting …
The global medical ventilators market, valued at USD 1.7 billion in 2023, is anticipated to grow at a robust CAGR of 9.1% over the next decade, exceeding USD 4 billion by 2033, according to recent research by FMI. This remarkable growth is fueled by technological advancements, the increasing prevalence of respiratory diseases, and rapid urbanization …
The global lacrimal devices market is projected to experience steady growth, with sales estimated at USD 32.1 million in 2025 and expected to rise to USD 57.0 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period between 2025 and 2035. The increasing adoption of procedures like …
Continue reading “Lacrimal Devices Industry to Reach USD 57.0 Million by 2035 at a 5.9% of CAGR”